Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The number of lateral hypothalamus orexin/hypocretin neurons contributes to individual differences in cocaine demand
Caroline B. Pantazis, Morgan H. James, Brandon S. Bentzley, et al.
Addiction Biology (2019) Vol. 25, Iss. 4
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

The hypocretin (orexin) system: from a neural circuitry perspective
Shi‐Bin Li, Luı́s de Lecea
Neuropharmacology (2020) Vol. 167, pp. 107993-107993
Closed Access | Times Cited: 111
Nucleus accumbens circuit disinhibits lateral hypothalamus glutamatergic neurons contributing to morphine withdrawal memory in male mice
Sheng Huan, Chao Lei, Yuan Yu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Intermittent self‐administration of fentanyl induces a multifaceted addiction state associated with persistent changes in the orexin system
Jennifer E. Fragale, Morgan H. James, Gary Aston‐Jones
Addiction Biology (2020) Vol. 26, Iss. 3
Open Access | Times Cited: 65
Sex Differences in Demand for Highly Palatable Foods: Role of the Orexin System
Linnea R. Freeman, Brandon S. Bentzley, Morgan H. James, et al.
The International Journal of Neuropsychopharmacology (2020) Vol. 24, Iss. 1, pp. 54-63
Open Access | Times Cited: 59
Recent perspectives on orexin/hypocretin promotion of addiction-related behaviors
F. Woodward Hopf
Neuropharmacology (2020) Vol. 168, pp. 108013-108013
Open Access | Times Cited: 50
Orexin Reserve: A Mechanistic Framework for the Role of Orexins (Hypocretins) in Addiction
Morgan H. James, Gary Aston‐Jones
Biological Psychiatry (2022) Vol. 92, Iss. 11, pp. 836-844
Open Access | Times Cited: 33
Orexin-1 Receptor Signaling in Ventral Pallidum Regulates Motivation for the Opioid Remifentanil
Aida Mohammadkhani, Jennifer E. Fragale, Caroline B. Pantazis, et al.
Journal of Neuroscience (2019) Vol. 39, Iss. 49, pp. 9831-9840
Open Access | Times Cited: 52
Sleep loss and addiction
Luis Angel López-Muciño, Fabio García‐García, Jonathan Cueto‐Escobedo, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 141, pp. 104832-104832
Closed Access | Times Cited: 26
Sleep Loss and Substance Use Disorders: An Issue from Adolescents to Adults
Ana Clementina Equihua-Benítez, Rodolfo Espinoza-Abad, Fabio García‐García
Behavioral Sciences (2025) Vol. 15, Iss. 2, pp. 220-220
Open Access
The Complexly Parcellated, Yet Quantitatively Reduced, Orexinergic/Hypocretinergic System of Humans
Illke B. Malungo, Ayanda Ngwenya, Mads F. Bertelsen, et al.
The Journal of Comparative Neurology (2025) Vol. 533, Iss. 2
Open Access
Drugs of abuse drive neurotransmitter plasticity that alters behavior: implications for mental health
Marta Pratelli, Nicholas C. Spitzer
Frontiers in Behavioral Neuroscience (2025) Vol. 19
Open Access
Persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for the fast acting opioid remifentanil
Aida Mohammadkhani, Morgan H. James, Caroline B. Pantazis, et al.
Brain Research (2019) Vol. 1731, pp. 146461-146461
Open Access | Times Cited: 41
Pivotal role of orexin signaling in the posterior paraventricular nucleus of the thalamus during the stress-induced reinstatement of oxycodone-seeking behavior
Jessica M. Illenberger, Francisco J. Flores‐Ramirez, Glenn Pascasio, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 7, pp. 647-660
Closed Access | Times Cited: 4
The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse
Morgan H. James, Jennifer E. Fragale, Shayna L. O’Connor, et al.
Neuropharmacology (2020) Vol. 183, pp. 108359-108359
Open Access | Times Cited: 29
Orexin-1 receptor signaling in ventral tegmental area mediates cue-driven demand for cocaine
Caroline B. Pantazis, Morgan H. James, Shayna L. O’Connor, et al.
Neuropsychopharmacology (2021) Vol. 47, Iss. 3, pp. 741-751
Open Access | Times Cited: 26
New directions in modelling dysregulated reward seeking for food and drugs
Robyn M. Brown, Christopher V. Dayas, Morgan H. James, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 132, pp. 1037-1048
Open Access | Times Cited: 23
Brain regulation of hunger and motivation: The case for integrating homeostatic and hedonic concepts and its implications for obesity and addiction
Ileana Morales
Appetite (2022) Vol. 177, pp. 106146-106146
Open Access | Times Cited: 18
Oxytocin and orexin systems bidirectionally regulate the ability of opioid cues to bias reward seeking
Giuseppe Giannotti, Francesca Mottarlini, Jasper A. Heinsbroek, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 17
Orexin-mediated Motivated Arousal and Reward Seeking.
Theresa E. Bjorness, Robert Greene
Peptides (2024) Vol. 180, pp. 171280-171280
Closed Access | Times Cited: 3
Contribution of hypothalamic orexin (hypocretin) circuits to pathologies of motivation
Aida Mohammadkhani, Caitlin Mitchell, Morgan H. James, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 3
Targeting the orexin system for prescription opioid use disorder: Orexin-1 receptor blockade prevents oxycodone taking and seeking in rats
Alessandra Matzeu, Rémi Martin‐Fardon
Neuropharmacology (2019) Vol. 164, pp. 107906-107906
Open Access | Times Cited: 28
The orexin-1 receptor antagonist SB-334867 reduces motivation, but not inhibitory control, in a rat stop signal task
Joost Wiskerke, Morgan H. James, Gary Aston‐Jones
Brain Research (2019) Vol. 1731, pp. 146222-146222
Open Access | Times Cited: 26
Targeting the Orexin System for Prescription Opioid Use Disorder
Alessandra Matzeu, Rémi Martin‐Fardon
Brain Sciences (2020) Vol. 10, Iss. 4, pp. 226-226
Open Access | Times Cited: 22
Introduction to the Special Issue: “Making orexin-based therapies for addiction a reality: What are the steps from here?”
Morgan H. James, Gary Aston‐Jones
Brain Research (2020) Vol. 1731, pp. 146665-146665
Open Access | Times Cited: 21
Use of drug purchase tasks in medications development research: orexin system regulation of cocaine and drug demand
Justin C. Strickland, Kevin W. Hatton, Lon R. Hays, et al.
Behavioural Pharmacology (2023) Vol. 34, Iss. 5, pp. 275-286
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top